Intermittent G-CSF (filgrastim) treatment cannot induce lymphocytosis in volunteers.
von Aulock
S
S
Boneberg
E M
EM
Hartung
T
T
D004334:Drug Administration Schedule; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000494:pharmacology*; D006098:Granulocytes / Q000187:drug effects*; D006801:Humans; D007964:Leukocytosis / Q000139:chemically induced*; D018655:Lymphocyte Count / Q000187:drug effects; D011994:Recombinant Proteins; D016176:T-Lymphocyte Subsets / Q000187:drug effects
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim